Browse Reports

Xenetic Biosciences, Inc. operates in the biotechnology sector focusing on developing and commercializing drug candidates using proprietary technologies such as PolyXen, ImuXen, OncoHist, and DNase I platform. The company engages in collaborative research and licensing agreements with partners like Pharmsynthez and SynBio, which hold exclusive rights in certain territories while allowing Xenetic to develop and commercialize products elsewhere. Clinical development activities include ongoing trials for ErepoXen in Russia and systemic DNase I technology trials in Israel. The company reported revenues of approximately $2.98 million and a net loss of $2.68 million for the fiscal year ended 2025, with a strong current ratio of 8.32 reflecting liquidity. Governance is overseen by a Board with diverse expertise, including scientific, financial, and operational backgrounds. Xenetic also maintains equity incentive plans and employee benefit programs.

Wellgistics Health, Inc. operates in the healthcare technology sector, focusing on pharmacy solutions, benefits verification, and digital health initiatives. The company is headquartered in Tampa, Florida, and is publicly traded on the NASDAQ Capital Market. Its business model includes commercialization and distribution of healthcare-related products and services through partnerships and joint ventures. Key recent initiatives include a joint venture with Kare PharmTech to market benefits verification products, implementation of PharmacyChain technology with DataVault AI, and expansion of access to pain management and medical food products through collaborations with Protega Pharmaceuticals and Tollo Health. The company has also introduced an XRP payment initiative aimed at enhancing healthcare infrastructure. Wellgistics completed its initial public offering in early 2025 and has since focused on expanding its technology platform and market reach.

Paramount Skydance Corporation (PSKY) is a media and entertainment company resulting from the merger of Paramount Global and Skydance Media, LLC. The company operates through three main segments: Studios, Direct-to-Consumer, and TV Media, reflecting its diversified content production and distribution activities. PSKY's governance structure includes a ten-member board with expertise in media, finance, and technology sectors. The company is currently pursuing a major acquisition of Warner Bros. Discovery, supported by a complex financing arrangement including PIPE investments, rights offerings, and secured credit facilities. Financially, PSKY reported a net loss for the fiscal year ended 2025, with liquidity ratios indicating moderate short-term financial stability. The company faces industry risks such as competitive pressures, evolving consumer behaviors, and regulatory challenges, alongside risks related to the integration of the WBD acquisition.

Creative Medical Technology Holdings, Inc. is a biotechnology company engaged in the development and commercialization of novel biological therapeutics primarily in immunotherapy, endocrinology, urology, neurology, and orthopedics. The company’s commercial operations are conducted mainly through its subsidiary Creative Medical Technologies, Inc., which sells disposable stem cell concentration kits (CaverStem® and FemCelz®) used in autologous procedures for erectile dysfunction and female sexual dysfunction. The company has expanded its research and development efforts into stem cell-based therapies for various diseases, including chronic lower back pain, Type 1 diabetes, and neurologic disorders, through subsidiaries ImmCelz, Inc., StemSpine, Inc., and AlloCelz LLC, although some subsidiaries have not yet commenced commercial activities. The company manages its business as a single operating segment and recognizes revenue upon delivery of its kits to customers. It has ongoing clinical trials, notably the ADAPT trial for chronic lower back pain using CELZ-201 (Olastrocel), which has reported positive interim data and completed enrollment. The company’s financials show limited revenue and significant net losses, with strong liquidity ratios as of the latest reporting period.

Arcellx, Inc. operates as a clinical-stage biopharmaceutical company developing innovative cell therapies and biologics. Its proprietary platforms include D-Domain, ddCAR, and ARC-SparX technologies, which are designed to target hematologic malignancies such as multiple myeloma, acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS). The company has advanced its lead candidate, anito-cel, through pivotal clinical trials and is conducting Phase 1 trials for ARC-SparX candidates. Arcellx has no commercial products and has incurred substantial operating losses since inception. The company collaborates with third parties, including Kite Pharma, for development and manufacturing. It maintains a strong liquidity position as of the end of 2025 but anticipates ongoing capital needs to support clinical development and potential commercialization. The company is subject to risks typical of clinical-stage biopharmaceutical firms, including regulatory approvals, clinical trial outcomes, manufacturing complexities, and competitive pressures.

Wealthfront Corp is a Palo Alto-based technology company founded in 2008 that provides a financial solutions platform primarily for digital natives born after 1980. The platform offers a broad range of automated financial products including cash management, investment advisory, borrowing and lending, and financial planning. The company’s business model focuses on automation to reduce costs and improve client experience, sharing savings with clients to build trust and encourage asset growth. Wealthfront’s clients are typically high earners with large liquid savings who prefer digital-first, seamless financial services. The company’s proprietary technology infrastructure supports a fully integrated brokerage and cash management platform, enabling features such as instant transfers and industry-leading APYs. Wealthfront generates most of its revenue from cash management and investment advisory fees, with recent expansion into home lending. The company had 391 employees as of January 2026, with a strong engineering culture. Financially, Wealthfront reported a net loss in fiscal 2026 following prior years of profitability, with liquidity ratios indicating a solid short-term financial position. The company faces risks related to market volatility, competition, regulatory compliance, and managing growth effectively.

Summit Networks Inc. was incorporated in 2014 and historically operated as a development-stage issuer exploring various business opportunities without sustained revenues. In 2025, the company completed a phase of internal development focused on organizational and governance improvements and began transitioning to a strategic acquisition platform targeting logistics enterprises in Asia. The company aims to build a scalable logistics platform through disciplined acquisitions of established, revenue-generating businesses, enhancing operational efficiency via governance standardization and digital integration. As of the end of 2025, Summit Networks had limited revenues, a net loss, and a significant stockholders' deficit, relying on shareholder support for liquidity. Governance and organizational structures were strengthened following regulatory clearance in early 2026. The company currently operates as a single segment with a small employee base supplemented by external professional services [S1].

Jazz Pharmaceuticals plc operates as a global biopharmaceutical company headquartered in Dublin, Ireland. The company develops, manufactures, and markets pharmaceutical products primarily focused on central nervous system disorders, including narcolepsy. Its key products include Xyrem and Xywav, treatments for narcolepsy symptoms such as cataplexy and excessive daytime sleepiness. Jazz also markets Epidiolex/Epidyolex and has expanded its portfolio through acquisitions, including Chimerix in 2025, which added Modeyso, a treatment for a rare brain tumor. The company maintains manufacturing facilities in Ireland, the UK, and the US. Jazz faces competition from authorized generic and branded products in its oxybate franchise and manages ongoing patent litigation related to these products. The company is subject to regulatory and pricing pressures, as well as supply chain risks related to tariffs and trade policies.

Coterra Energy Inc. is a publicly traded oil and gas exploration and production company headquartered in Houston, Texas. The company operates primarily in the natural gas and oil sectors, with expertise in natural gas transportation and marketing. It reported annual revenue of approximately $7.645 billion and net income of $1.717 billion for the fiscal year ended December 31, 2025. Coterra maintains liquidity with a current ratio of 1.19 and cash ratio of 0.23 as of the same date. The company is currently pursuing an all-stock merger with Devon Energy Corporation, which would combine their assets and operations, subject to regulatory and shareholder approvals. The board of directors comprises experienced industry professionals with backgrounds in exploration, production, finance, and governance.

Webster Financial Corporation is a regional financial services company headquartered in Stamford, Connecticut. It operates primarily through its wholly-owned subsidiary, Webster Bank, N.A., serving markets including Connecticut and New York. The company offers banking products and services typical of regional banks, including commercial and consumer loans, deposits, and wealth management. Webster Financial is publicly traded on the New York Stock Exchange under the ticker WBS and has multiple classes of preferred stock. The company has a seasoned management team and board with deep experience in financial services and risk management. In early 2026, Webster agreed to be acquired by Banco Santander in a cash-and-stock transaction valued at $12.3 billion, subject to stockholder and regulatory approvals. The acquisition is a major corporate milestone and has led to the postponement of the 2026 Annual Meeting of Stockholders. Financial disclosures for fiscal year 2025 show revenue of approximately $2.9 billion and net income of about $1.0 billion, with earnings per share near $5.90. The company maintains dividend payments and has been covered in recent news for earnings performance and the acquisition agreement.

Intercorp Financial Services Inc. is a financial services company with disclosed financial results for the fiscal year ending December 31, 2024. The company reported net income of PEN 1.3 billion and held over PEN 12.6 billion in cash and cash equivalents. Earnings per share were reported at PEN 11.376. While specific details about the company's sector, industry, and geographic operations are not provided, the company is subject to SEC reporting requirements, indicating a level of regulatory compliance and transparency.

CEMEX SAB DE CV is a multinational company engaged primarily in the production and distribution of cement, aggregates, and related building materials. The company operates globally, with a business model that requires securing and maintaining numerous regulatory approvals, licenses, and permits to operate production facilities and quarries. Its operations are subject to environmental laws, including greenhouse gas emissions regulations, and it faces legal and regulatory challenges in various jurisdictions. The company reported $16.2 billion in revenue and $960 million in net income for the fiscal year ended December 31, 2024, with liquidity ratios indicating moderate short-term financial flexibility. CEMEX's business is influenced by local market conditions, regulatory compliance, and environmental standards, which can affect operational continuity and costs.

AXIA Energia S.A. operates primarily in the electricity generation and transmission sectors in Brazil, with additional activities in telecommunications. The company is listed on the Brazilian stock exchange B3 and the NYSE through ADSs. It maintains a diversified energy portfolio including hydroelectric, wind, gas-fired thermoelectric, and solar plants, complemented by transmission infrastructure. AXIA Energia invests heavily in innovation and R&D, focusing on energy storage, digitalization, green hydrogen, and hybrid renewable systems. The company collaborates with Cepel, a leading Brazilian energy research institution, to advance technological development. Financially, AXIA Energia reported revenues exceeding R$40 billion and net income over R$10 billion for 2024, supported by solid liquidity and capital resources. The company adheres to robust corporate governance practices aligned with Brazilian law and NYSE requirements for foreign private issuers. Recent strategic moves include delisting certain shares from international markets and consolidating share classes to enhance governance.

Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated to thyroid-related diseases. The company develops and commercializes proprietary microwave ablation (MWA) medical devices, including needles and therapeutic apparatus, and is advancing AI-integrated robotic systems for thyroid treatment. Its products are sold primarily in China through direct sales, deliverers, and distributors, with a growing hospital customer base including top-tier Grade III hospitals. Baird Medical ranked first in China for MWA needle sales revenue and volume in 2022 and third in overall MWA medical device sales revenue. The company operates primarily in one reporting segment and generates most of its revenue from the PRC, with additional sales in Hong Kong, the United States, and other countries. The business is subject to regulatory, operational, and market risks typical of medical device companies in China.

Cre8 Enterprise Ltd operates primarily in the financial printing services sector, providing integrated IPO and non-IPO financial printing services. Its services include preparation of IPO prospectuses, annual reports, circulars, compliance documents, and customized marketing materials. The company’s revenue increased notably in 2025, driven by growth in IPO-related services, while non-IPO services saw a slight decline due to the adoption of paperless listing regimes. The company completed its initial public offering in July 2025, raising approximately $5.8 million, and expanded its geographic footprint by acquiring Upperhand Investment Limited in 2026, which operates in Japan. Financially, the company reported revenues of approximately $16.8 million and net income of $0.68 million for the fiscal year ending December 31, 2025. Liquidity ratios indicate a stable short-term financial position. The company’s governance structure includes a board with independent directors and established audit, compensation, and nominating committees.

Intelligent Living Application Group Inc. operates through its subsidiaries, primarily manufacturing mechanical locksets in China for sale mainly in North America. The company offers a range of products compliant with ANSI standards, targeting various customer segments from premium to economy. It has a long history of manufacturing and has invested in automated production lines and quality certifications. The company faces challenges from US tariffs on imports, competitive pricing pressures, and reliance on a limited number of large customers. It is pursuing market diversification in Asia and product mix optimization to improve profitability.

HiTek Global Inc. is a publicly reporting company that files annual reports on Form 20-F with the SEC. The company’s latest audited financial statements as of December 31, 2025, show revenues of approximately $6.54 million and net income of $180,142. The company maintains a strong liquidity position with current assets of about $40.79 million against current liabilities of $4.95 million, resulting in a current ratio of 8.23. The company’s operating expenses exceeded gross profit, leading to an operating loss, but other income sources such as investment gains and interest income contributed positively to net income. The company completed a 50-for-1 reverse stock split of its Class A ordinary shares in April 2026, with shares continuing to trade on Nasdaq under the ticker HKIT. The board oversees insider trading policies and cybersecurity risk management, with no material cybersecurity incidents reported recently. Recent news coverage indicates the company experienced a loss in fiscal year 2024, suggesting some fluctuations in financial performance.

MEXICAN ECONOMIC DEVELOPMENT INC is a Mexican corporation with significant operations primarily in Mexico, which accounted for 64% of its consolidated revenues in 2025. The company operates in sectors affected by commodity prices, energy costs, and geopolitical risks. It faces operational challenges including supply chain disruptions, inflationary pressures, and regulatory changes, particularly related to environmental and sustainability reporting. Currency fluctuations, especially of the Mexican peso against the U.S. dollar, also impact its financial results. The company has disclosed a material weakness in IT general controls over financial accounting but reported no material errors in its financial statements.

Apollomics Inc. is a Cayman Islands exempted company operating through subsidiaries in the US, Australia, Hong Kong, and China. It focuses on discovering and developing oncology therapies targeting difficult-to-treat and treatment-resistant cancers. The company’s pipeline includes three clinical-stage product candidates, with vebreltinib as the lead candidate. Apollomics generates revenue primarily through licensing and collaboration agreements, such as the $10 million license deal with LaunXP International for development and commercialization in parts of Asia. The company has no significant physical assets and operates with leased facilities. Financially, Apollomics has incurred recurring losses since inception, with an accumulated deficit exceeding $700 million as of the end of 2025. The company’s liquidity position as of December 31, 2024, included cash and equivalents of approximately $9.77 million and a current ratio of 1.39. Management has expressed substantial doubt about the company’s ability to continue as a going concern without additional financing. In March 2026, the company secured a $2 million unsecured bridge loan from its CEO to support ongoing clinical operations. The company’s shares have experienced trading halts and resumptions in late 2024, with compliance achieved on Nasdaq bid price requirements.

UTStarcom Holdings Corp. develops and supplies IP-based broadband packet optical transport and wireless/fixed-line access products and solutions to telecom carriers globally, with a focus on Japan, India, and China. Its product suite aims to reduce network complexity and enable cost-effective deployment and upgrades. The company operates two main segments: Equipment, which includes network infrastructure and application products, and Services, which provides support and operational services. In 2025, net sales totaled approximately $9.0 million, predominantly from services. The company reported a net loss and maintains liquidity with cash and equivalents of $33.8 million as of year-end 2025. UTStarcom faces foreign exchange risks due to its multinational operations and currency controls in China. Management has identified and is addressing material weaknesses in financial reporting controls. The company has an ongoing share repurchase program and has recently secured significant contracts and leadership appointments.

iHuman Inc. develops and markets a broad range of intellectual development products for children, combining technology, original content, and interactive features. Its offerings include online educational apps, offline books and cards, smart reading and writing pens, and animated content such as the Cosmicrew series. The company serves both institutional customers, including kindergartens across China, and family users. It has expanded its physical presence with experience centers to showcase integrated product solutions. iHuman's business model includes subscription-based online content, sales of offline products, and licensing of animated content. The company emphasizes data privacy and security and competes on product quality, content originality, technology, and brand recognition. It operates under a Cayman Islands holding company structure with subsidiaries and a VIE in China, navigating complex regulatory and foreign exchange environments.

Ebang International Holdings Inc. is a Cayman Islands holding company with subsidiaries primarily operating in China and overseas. The company has diversified its business across Fintech services, renewable energy, telecommunications, and blockchain products. Its Fintech segment includes proprietary platforms such as Ebonex (cryptocurrency exchange) and EbonFX (cross-border payment and foreign exchange). The renewable energy business, established in late 2024, focuses on solar and battery storage solutions and SaaS data analytics. Revenue growth in 2025 was driven by renewable energy product sales and rental income, while the company continues to invest in research and development for ASIC chip design and Fintech platform enhancements. The company maintains strong liquidity with significant cash reserves and a high current ratio as of the end of 2025.

Carlisle Companies Inc. is a publicly traded company with recent quarterly and annual SEC filings disclosing its financial performance. The company reported approximately $5.0 billion in revenue for the full year 2024 and net income of $127.7 million for Q1 2026. Liquidity metrics as of March 31, 2026, show a strong current ratio of 3.38 and a cash ratio of 1.28, indicating solid short-term financial health. Recent earnings announcements and call transcripts provide insight into the company's operational results and market reception. News coverage notes a decline in organic revenues in Q1 2026 despite earnings surpassing prior expectations, reflecting mixed business performance signals.

First Industrial Realty Trust Inc is a publicly traded real estate investment trust (REIT) listed on the New York Stock Exchange under the ticker FR. The company operates in the industrial real estate sector, focusing on owning, managing, and developing industrial properties. It reported revenues of approximately $194.8 million and net income of $143.1 million for the quarter ended March 31, 2026, with earnings per share of $1.08. The company maintains liquidity with cash and cash equivalents of $37.1 million as of the same period. It has secured substantial unsecured term loans totaling $800 million in early 2026, supporting its capital structure and operations. The board of directors expanded in 2026, and the company has an employee bonus plan tied to key financial performance metrics including funds from operations per share and same store net operating income growth.

CME Group Inc. is a leading global derivatives marketplace operator, providing trading and clearing services across a wide range of asset classes including interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and cryptocurrencies. The company operates multiple exchanges (CME, CBOT, NYMEX, COMEX) and electronic trading platforms such as CME Globex and CME Direct. CME Group also offers market data, benchmark indices, and analytics services. Its clearing house acts as central counterparty to mitigate credit risk. The customer base spans professional traders, financial institutions, corporations, governments, and retail investors. CME Group pursues growth through product innovation, geographic expansion, retail market development, and diversification into environmental and crypto markets. The company maintains robust technology infrastructure and risk management practices to support its operations.

RLI Corp. operates as a specialty insurance company focusing on niche property, casualty, and surety insurance products. It conducts business through three main subsidiaries: RLI Insurance Company, Mt. Hawley Insurance Company, and Contractors Bonding and Insurance Company. These subsidiaries provide admitted and non-admitted insurance coverage across all U.S. states and territories. The company targets specialty markets where risks do not fit standard underwriting criteria, competing on coverage availability and service rather than price. Distribution is primarily through wholesale and retail brokers, independent agents, carrier partners, and select direct sales. RLI also engages in reinsurance and limited managing general agent agreements. The company’s financials for Q1 2026 show revenues of $423.87 million and net income of $54.885 million, supported by strong liquidity with over $723 million in cash and equivalents.

Orchid Island Capital, Inc. is an investment company focused on Agency Residential Mortgage-Backed Securities (RMBS), which are securities primarily backed by single-family residential mortgage loans. The company does not handle personal borrower information. It relies on its Manager's information systems for operations and cybersecurity risk management, with oversight by the Board and Audit Committee. The company maintains a significant cash position and regularly reports on its portfolio characteristics and financial results. It also pays dividends to shareholders and communicates regularly through earnings calls and press releases.

YY Group Holding Ltd. operates as a technology-enabled service provider delivering integrated facilities management (IFM), manpower outsourcing, and other related services primarily in Singapore, Malaysia, and other Southeast Asian countries. The IFM segment offers cleaning, property and facility management, security, and pest control services under unified contracts, supported by digital tools like the YY Smart iClean App that integrates IoT technology for operational efficiency. The manpower outsourcing segment is anchored by the YY Circle Super App, an online platform facilitating labor matching for part-time and full-time work across various industries. Other services include digital marketing, web development, and property rental, with ongoing development of a digital facilities management platform called 24IFM. The company has pursued growth through acquisitions and partnerships, expanding its service capabilities and regional footprint. Revenue increased significantly from 2024 to 2025, driven by both IFM and manpower outsourcing segments, though net losses widened due to increased expenses including share-based compensation and asset impairments. Liquidity metrics as of end-2024 show a current ratio of 1.69, indicating moderate short-term financial flexibility. The company faces operational challenges including talent shortages, regulatory compliance, and balancing supply and demand in its staffing platform.

MINISO Group Holding Ltd is a Cayman Islands holding company operating a global retail business primarily through franchise agreements with retail partners. These partners operate stores independently, selecting products from MINISO's offerings and managing their own staff and operational costs. The company has expanded its store base significantly, including a growing number of directly operated stores, particularly in overseas markets such as the U.S. Financial disclosures show increasing revenue, gross profit, and net income, with investments in store operations and brand promotion driving selling and distribution expenses. The company maintains a strong liquidity position with cash and equivalents exceeding RMB6 billion as of the end of 2024. MINISO is listed on the NYSE with ADSs and is subject to U.S. and PRC tax regulations, including considerations related to PFIC status and PRC resident enterprise classification. Corporate governance reflects controlled company status with key executives holding majority voting power.

Selective Insurance Group, Inc. is a New Jersey-based insurance holding company with a history dating back to 1926. It operates exclusively in the U.S. through ten property and casualty insurance subsidiaries, nine of which are admitted carriers writing standard market lines, and one non-admitted carrier writing excess and surplus lines. The company’s business is organized into four segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. It distributes products solely through independent agents and wholesale brokers. The company’s Standard Commercial Lines segment serves commercial enterprises primarily in 36 states and DC, while Standard Personal Lines serves individuals in 15 states and includes flood insurance nationwide via the NFIP Write Your Own program. The E&S Lines segment serves commercial customers with high-risk exposures nationwide. The Investments segment manages premiums and capital through fixed income, equity, and alternative investments. The company emphasizes a unique operating model with empowered decision-makers, franchise-value distribution relationships, technology integration, and a focus on customer experience and employee engagement. It holds strong financial strength ratings from major rating agencies and maintains a disciplined underwriting approach with a focus on profitability and risk management. Geographic expansion and technology adoption, including AI, are key strategic priorities.

Guochun International Inc. was incorporated in 2018 and initially developed a messenger application. In June 2022, the company underwent a change in ownership and management, ceasing its prior business plans and shifting focus to acquiring a new business. It currently has no operations or employees and relies on its CEO for management and consulting services. The company faces intense competition from better-resourced entities in identifying and acquiring a viable business. It has no current agreements for a business combination and limited capital resources, which may constrain its ability to consummate a transaction. The company is subject to various risks including economic conditions, regulatory compliance, and management concentration.

FirstCash Holdings, Inc. is a company operating primarily in the pawn industry and retail point-of-sale payment solutions through its subsidiary AFF. The business model centers on providing pawn loans secured by tangible personal property, including jewelry, electronics, and other goods, which serve as collateral. The company also generates retail sales from merchandise acquired through collateral forfeitures and direct sales. The Retail POS payment solutions segment offers lease-to-own and retail financing products across a network of merchant partners. The company operates across multiple geographic regions including the U.S., Latin America, and the U.K. FirstCash maintains strong liquidity and has demonstrated growth in operating cash flow and profitability in recent periods. The company actively manages its inventory, particularly gold jewelry, which provides flexibility in cash flow management. Capital expenditures and acquisitions are significant components of investing activities, supporting growth and expansion.

Nasdaq, Inc. operates as a technology platform powering global financial markets and innovation. It manages three business segments: Capital Access Platforms (including Data & Listing Services, Index, and Workflow & Insights), Financial Technology (including Financial Crime Management, Regulatory, and Capital Markets Technology), and Market Services (operating multiple exchanges and clearing services). Nasdaq provides market data, listing services, index licensing, analytics, and technology solutions to a broad client base including institutional investors, asset managers, and public companies. The company reported strong financial performance in 2025, with growth in revenues and net income, supported by increased IPO activity, index assets under management, and subscription revenues. Nasdaq's liquidity position as of Q1 2026 remains stable with a current ratio of 1.0 and significant cash reserves.

Apogee Enterprises, Inc., incorporated in 1949, is a leading provider of architectural building products and services, and high-performance coated materials. The company operates four main segments: Architectural Metals, Architectural Services, Architectural Glass, and Performance Surfaces, which collectively serve primarily the North American non-residential construction market. Its products include aluminum window and curtainwall systems, architectural glass with proprietary coatings, and coated materials for various applications. Apogee sells through a mix of direct sales, independent representatives, and distributors. The company’s strategy focuses on customer-centric growth, portfolio strengthening through organic and inorganic investments, and operational excellence. Fiscal 2026 execution included integration of acquisitions, cost structure management, and safety improvements. The company faces cyclical demand influenced by economic conditions and construction industry trends, and competes in fragmented markets emphasizing quality, service, and technical capabilities [S1].

Polibeli Group Ltd is a Cayman Islands exempted company engaged in global integrated digital supply chain operations, focusing on international consumer products trading. The company operates through subsidiaries in Asia, the U.S., Europe, and Australasia, with a diversified geographic footprint and multiple local currencies as functional currencies. Polibeli completed a business combination with Chenghe Acquisition II Co. in August 2025, after which its shares began trading on Nasdaq. The company maintains related party arrangements for procurement, supply, and financing with entities under common control. Polibeli’s workforce has been adjusted in line with operational development stages, and it has established equity incentive plans to attract and retain personnel. The company reported revenues of approximately $26.4 million USD and a net loss of about $5.97 million USD for the fiscal year ended December 31, 2025, with liquidity ratios indicating current liabilities exceeding current assets. Polibeli has not paid dividends and plans to retain earnings for business growth. The company is subject to tax regimes in the Cayman Islands, Japan, Indonesia, and the U.S., and follows U.S. GAAP accounting standards with disclosures on critical accounting estimates.

Huize Holding Ltd operates an online insurance brokerage platform primarily in China and Hong Kong. The company distributes insurance products underwritten by insurer partners, focusing on life and health insurance products, which constitute the majority of its business. It earns brokerage commissions based on premiums paid by insurance clients, with higher commissions from life and health insurance products. The company maintains contracts with numerous insurer partners and emphasizes client acquisition through marketing, user education, and partnerships with user traffic channels. Huize Holding Ltd invests in data analytics and technology to improve operating efficiency and client conversion. The company is subject to evolving regulatory frameworks in China and operates through a holding company structure with subsidiaries and a VIE in China. Its financial performance includes reported revenue of USD 226.3 million and net income of USD 0.578 million for 2025, with liquidity ratios indicating moderate short-term financial strength.